
$1.605
+0.057 (+3.55%)Al cierre
- Máximo
- 1.700
- Apertura
- 1.670
- Precio medio ponderado por volumen
- 1.57
- Volumen
- 856.52K
- Capitalización
- 6.51M
- Mínimo
- 1.402
- Importe
- 1.34M
- EV/EBITDA, TTM
- 0.00
22nd Century Group, Inc. is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. The Company manufactures and distributes combustible tobacco products containing minimally or non-addictive levels of nicotine. Additionally, the Company provides turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands. The Company's product, VLN cigarette has 95% less nicotine than the traditional cigarette. The Company operates through a single segment named Tobacco. It is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. It is also engaged in the sale of its proprietary low nicotine content cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM.
Análisis de IA of 22nd Century Group Inc (XXII)
VenderCurrently, 22nd Century Group Inc (XXII) is not a good buy. The stock has dropped 99.99% year-to-date and 61.60% in the last five days, indicating severe volatility and investor loss. The RSI is extremely low at 7.524, suggesting the stock is oversold, but this could also indicate a lack of buying interest. With a forward P/E ratio of 0 and a gross margin of -10.23%, the company is struggling financially. The main risk is the upcoming earnings report on November 16, which is expected to lead to a further price drop of approximately 34.82%.
Recomendaciones de analistas (1)
Roth MKM
$80
2023-08-23
Roth MKM
2023-08-23
Precio objetivo
$80
Alliance Global Partners
—
2023-08-17
Alliance Global Partners
2023-08-17
Precio objetivo
—
TD Cowen
$40
2023-08-15
TD Cowen
2023-08-15
Precio objetivo
$40
Dawson James
$7.5
2023-08-15
Dawson James
2023-08-15
Precio objetivo
$7.5
Dawson James
$16
2023-07-03
Dawson James
2023-07-03
Precio objetivo
$16
Métricas de valoración
Cronología de eventos
Noticias
7.510-29Newsfilter22nd Century Partners with Gopuff for Direct-to-Consumer Sales
8.510-28NewsfilterPinnacle Brand Expansion into 13 States Enhances Distribution Footprint
5.010-26Newsfilter22nd Century Group Expands Pinnacle Pure Product Line
7.510-23NewsfilterKraig Biocraft Advances Commercialization of Spider Silk Technology
9.510-22Newsfilter22nd Century Group Reports 66% Revenue Growth in Q3
Preguntas frecuentes sobre XXII, respondidas por Alphio AI
22nd Century Group, Inc. is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. The Company manufactures and distributes combustible tobacco products containing minimally or non-addictive levels of nicotine. Additionally, the Company provides turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands. The Company's product, VLN cigarette has 95% less nicotine than the traditional cigarette. The Company operates through a single segment named Tobacco. It is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. It is also engaged in the sale of its proprietary low nicotine content cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. It operates in the Consumer Non-Cyclicals sector (CIGARETTES industry).
Currently, 22nd Century Group Inc (XXII) is not a good buy. The stock has dropped 99.99% year-to-date and 61.60% in the last five days, indicating severe volatility and investor loss. The RSI is extremely low at 7.524, suggesting the stock is oversold, but this could also indicate a lack of buying interest. With a forward P/E ratio of 0 and a gross margin of -10.23%, the company is struggling financially. The main risk is the upcoming earnings report on November 16, which is expected to lead to a further price drop of approximately 34.82%.
1 analysts cover XXII: 1 rate it Buy, 0 Hold and 0 Sell.
Comunidad
Más ↗
Artículos relacionados
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.
